JP2024525780A5 - - Google Patents
Info
- Publication number
- JP2024525780A5 JP2024525780A5 JP2024501976A JP2024501976A JP2024525780A5 JP 2024525780 A5 JP2024525780 A5 JP 2024525780A5 JP 2024501976 A JP2024501976 A JP 2024501976A JP 2024501976 A JP2024501976 A JP 2024501976A JP 2024525780 A5 JP2024525780 A5 JP 2024525780A5
- Authority
- JP
- Japan
- Prior art keywords
- interleukin
- receptor
- inhibitor
- residue
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221806P | 2021-07-14 | 2021-07-14 | |
| US63/221,806 | 2021-07-14 | ||
| PCT/US2022/037221 WO2023288028A2 (en) | 2021-07-14 | 2022-07-14 | Peptide inhibitors of interleukin-23 receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525780A JP2024525780A (ja) | 2024-07-12 |
| JP2024525780A5 true JP2024525780A5 (cg-RX-API-DMAC7.html) | 2025-07-24 |
Family
ID=84920532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501976A Pending JP2024525780A (ja) | 2021-07-14 | 2022-07-14 | インターロイキン-23受容体のペプチド阻害剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240409598A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4370531A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024525780A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240034222A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117999274A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022310354A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3226539A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024000762A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202332683A (cg-RX-API-DMAC7.html) |
| UY (1) | UY39856A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023288028A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| CA2949215C (en) | 2014-05-16 | 2023-03-14 | Protagonist Therapeutics, Inc. | .alpha.4.beta.7 integrin thioether peptide antagonists |
| SG10201810154WA (en) | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| WO2018022937A1 (en) | 2016-07-27 | 2018-02-01 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases |
| WO2019157268A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| MX2022008740A (es) | 2020-01-15 | 2022-09-23 | Janssen Biotech Inc | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| KR20240034224A (ko) | 2021-07-14 | 2024-03-13 | 얀센 바이오테크 인코포레이티드 | 인터류킨-23 수용체의 지질화된 펩티드 억제제 |
| EP4652179A1 (en) * | 2023-01-16 | 2025-11-26 | Janssen Pharmaceutica NV | Lipidated peptide inhibitors of interleukin-23 receptor |
| EP4652180A2 (en) * | 2023-01-16 | 2025-11-26 | Janssen Pharmaceutica NV | Peptide inhibitors of interleukin-23 receptor |
| TW202440615A (zh) * | 2023-01-16 | 2024-10-16 | 比利時商健生藥品公司 | 介白素-23受體之肽抑制劑 |
| KR20250139359A (ko) * | 2023-01-31 | 2025-09-23 | 얀센 파마슈티카 엔브이 | 인터류킨-23 수용체의 결정질 펩티드 억제제의 제조 방법 |
| AU2024233524A1 (en) * | 2023-03-03 | 2025-10-16 | Janssen Pharmaceutica Nv | Interleukin-23 receptor antagonist peptides for use in the treatment of psoriasis |
| EP4471048A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471049A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CN121794283A (zh) | 2023-09-08 | 2026-04-03 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| CN121909205A (zh) | 2023-09-08 | 2026-04-21 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026026816A1 (zh) * | 2024-07-30 | 2026-02-05 | 西藏海思科制药有限公司 | 白介素-23受体的肽抑制剂及其用途 |
| WO2026041110A1 (zh) * | 2024-08-22 | 2026-02-26 | 上海瀚辰星泰医药科技有限公司 | 一种多肽化合物及其应用 |
| WO2026046292A1 (zh) * | 2024-08-28 | 2026-03-05 | 西藏海思科制药有限公司 | 白介素-23受体的肽抑制剂的药物组合物及其制备方法和用途 |
| WO2026138829A1 (zh) * | 2024-12-23 | 2026-07-02 | 上海医药集团股份有限公司 | 多肽抑制剂及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9605027B2 (en) * | 2011-06-14 | 2017-03-28 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| SG10201810154WA (en) * | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| HK1257747A1 (zh) * | 2015-07-15 | 2019-10-25 | Protagonist Therapeutics Inc. | 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途 |
| US10787490B2 (en) * | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP2020505352A (ja) * | 2017-01-18 | 2020-02-20 | プロタゴニスト セラピューティクス, インコーポレイテッド | インターロイキン−23受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| CA3104418A1 (en) * | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2020311395A1 (en) * | 2019-07-10 | 2022-02-03 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| SMT202500254T1 (it) * | 2020-01-15 | 2025-09-12 | Janssen Biotech Inc | Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie |
-
2022
- 2022-07-14 CA CA3226539A patent/CA3226539A1/en active Pending
- 2022-07-14 UY UY0001039856A patent/UY39856A/es unknown
- 2022-07-14 JP JP2024501976A patent/JP2024525780A/ja active Pending
- 2022-07-14 EP EP22842905.6A patent/EP4370531A4/en active Pending
- 2022-07-14 AU AU2022310354A patent/AU2022310354A1/en not_active Abandoned
- 2022-07-14 CN CN202280061973.9A patent/CN117999274A/zh active Pending
- 2022-07-14 TW TW111126555A patent/TW202332683A/zh unknown
- 2022-07-14 WO PCT/US2022/037221 patent/WO2023288028A2/en not_active Ceased
- 2022-07-14 KR KR1020247004772A patent/KR20240034222A/ko active Pending
- 2022-07-14 US US18/579,062 patent/US20240409598A1/en active Pending
- 2022-07-14 MX MX2024000762A patent/MX2024000762A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024525732A5 (cg-RX-API-DMAC7.html) | ||
| JP2024525723A5 (cg-RX-API-DMAC7.html) | ||
| JP2022540154A5 (cg-RX-API-DMAC7.html) | ||
| KR101899803B1 (ko) | 소듐 (2r,5s,13ar)-7,9-디옥소-10-((2,4,6-트리플루오로벤질)카르바모일)-2,3,4,5,7,9,13,13a-옥타히드로-2,5-메타노피리도[1',2':4,5]피라지노[2,1-b][1,3]옥사제핀-8-올레이트 | |
| JP6606692B2 (ja) | (2R,5S,13AR)−8−ヒドロキシ−7,9−ジオキソ−N−(2,4,6−トリフルオロベンジル)−2,3,4,5,7,9,13,13A−オクタヒドロ−2,5−メタノピリド[1’,2’:4,5]ピラジノ[2,1−b][1,3]オキサゼピン−10−カルボキサミドの結晶形 | |
| US11634418B2 (en) | Amino acid compounds and methods of use | |
| US20220135513A1 (en) | Methods of manufacturing treprostinil and treprostinil derivative prodrugs | |
| EP3962602A1 (en) | Itaconic acid derivatives and uses thereof in treating an inflammatory disease or a disease associated with an undesirable immune response | |
| JP2025134806A5 (cg-RX-API-DMAC7.html) | ||
| CN1104238C (zh) | 霉酚酸盐的包有肠溶衣的药物组合物 | |
| TW202332683A (zh) | 介白素-23受體之肽抑制劑 | |
| US10703731B2 (en) | Process for the preparation of Trisodium (4- {[1S,3R)-1-([1,1′-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl]amino}-4-oxobutanoate)-(N-petanoyl-N-{[2′-(1H-tetrazol-1-1D-5-yl)[1,1′-biphenyl]-4-yl]methyl}- L-valinate) and its polymorphs thereof | |
| JP2023504184A5 (cg-RX-API-DMAC7.html) | ||
| JP2023511551A5 (cg-RX-API-DMAC7.html) | ||
| CN115066418A (zh) | 具有抗炎性质的羧基衍生物 | |
| CN102264694B (zh) | 用于制备伏立诺他的方法 | |
| JP5345065B2 (ja) | デプシペプチドおよびその治療的使用 | |
| EP4237408A1 (en) | Itaconic acid derivatives | |
| JP2023513658A5 (cg-RX-API-DMAC7.html) | ||
| JP2014511844A5 (cg-RX-API-DMAC7.html) | ||
| WO2022090714A1 (en) | Novel compounds | |
| JP2012516883A (ja) | アクタガルジン誘導体 | |
| JP2019519478A (ja) | ペプチド−オリゴ尿素フォルダマー化合物及びそれらの使用方法 | |
| JP2026503110A (ja) | インターロイキン-23受容体の脂質付加ペプチド阻害剤の製剤 | |
| JP2012524775A5 (cg-RX-API-DMAC7.html) |